Thermo Fisher Scientific Inc.
TMO · NYSE
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,621,000 | $1,615,000 | $1,515,000 | $1,824,000 |
| Dep. & Amort. | $662,000 | $685,000 | $706,000 | $740,000 |
| Deferred Tax | -$127,000 | -$322,000 | -$279,000 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $2,151,000 | -$726,000 | -$1,425,000 | $594,000 |
| Other Non-Cash | -$2,068,000 | $147,000 | $206,000 | $132,000 |
| Operating Cash Flow | $2,239,000 | $1,399,000 | $723,000 | $3,290,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$404,000 | -$294,000 | -$362,000 | -$480,000 |
| Net Acquisitions | -$4,037,000 | $0 | $0 | $0 |
| Inv. Purchases | -$40,000 | -$47,000 | -$264,000 | $0 |
| Inv. Sales/Matur. | $254,000 | $0 | $0 | $0 |
| Other Inv. Act. | $104,000 | $53,000 | $99,000 | $500,000 |
| Investing Cash Flow | -$4,123,000 | -$288,000 | -$527,000 | $20,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,000,000 | -$787,000 | $2,002,000 | -$2,500,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $2,000,000 | $0 | -$2,000,000 | -$1,000,000 |
| Dividends Paid | -$163,000 | -$162,000 | -$149,000 | -$149,000 |
| Other Fin. Act. | -$469,000 | -$42,000 | $45,000 | -$17,000 |
| Financing Cash Flow | -$632,000 | -$991,000 | -$102,000 | -$3,666,000 |
| Forex Effect | -$75,000 | $311,000 | $37,000 | -$273,000 |
| Net Chg. in Cash | -$2,592,000 | $431,000 | $131,000 | -$630,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,603,000 | $4,172,000 | $4,040,000 | $4,670,000 |
| End Cash | $2,011,000 | $4,603,000 | $4,172,000 | $4,040,000 |
| Free Cash Flow | $1,835,000 | $1,105,000 | $361,000 | $2,810,000 |